Form 4: CareDx CEO Sells Shares Under 10b5-1 Plan

CareDx Inc. President and CEO, John Walter Hanna Jr., sold 10,156 shares of common stock on January 15, 2026, under a pre-arranged 10b5-1 trading plan.

Summary

• John Walter Hanna Jr., President and CEO, and a Director of CareDx, Inc. (CDNA), reported a sale of common stock.
• The transaction involved the disposition of 10,156 shares of CareDx common stock.
• The sale occurred on January 15, 2026, at a weighted average price of $21.052 per share.
• The shares were sold in multiple transactions within a price range of $21.00 to $21.18 per share.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hanna on December 13, 2024.
• Following this transaction, Mr. Hanna beneficially owns 616,885 shares of CareDx common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading, indicating a planned financial move rather than a reaction to new negative information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, which demonstrates adherence to corporate governance best practices and mitigates concerns about trading on material non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived by investors as a signal of reduced confidence in the company's near-term prospects or valuation, although the 10b5-1 plan lessens this impact.

Risks

• Investor perception of insider selling could potentially lead to negative sentiment, despite the transaction being pre-planned under a 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine disclosure for publicly traded companies and does not inherently provide direct insight into broader industry trends. However, investor sentiment towards a company can sometimes be influenced by insider buying or selling activity within its specific sector, such as the diagnostics or healthcare technology industry where CareDx operates.

Corporate Governance

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, potentially influencing their investment decisions, though the 10b5-1 plan provides context that it was a pre-planned transaction.

Key Dates

Keywords

CareDx, CDNA, Form 4, insider trading, stock sale, 10b5-1 plan, CEO, director, executive compensation